Prostatic Cancer Clinical Trials in Omaha, Nebraska
2 recruitingOmaha, Nebraska
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Prostatic Cancer, Castration-Resistant
Novartis Pharmaceuticals130 enrolled50 locationsNCT07047118
Recruiting
Not Applicable
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
Prostatic Cancer
University of Nebraska53 enrolled1 locationNCT05754580